- Open Access
Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease
Acta Neuropathologica Communications volume 9, Article number: 70 (2021)
Huntington’s disease (HD) is a late onset, inherited neurodegenerative disorder for which early pathogenic events remain poorly understood. Here we show that mutant exon 1 HTT proteins are recruited to a subset of cytoplasmic aggregates in the cell bodies of neurons in brain sections from presymptomatic HD, but not wild-type, mice. This occurred in a disease stage and polyglutamine-length dependent manner. We successfully adapted a high-resolution correlative light and electron microscopy methodology, originally developed for mammalian and yeast cells, to allow us to correlate light microscopy and electron microscopy images on the same brain section within an accuracy of 100 nm. Using this approach, we identified these recruitment sites as single membrane bound, vesicle-rich endolysosomal organelles, specifically as (1) multivesicular bodies (MVBs), or amphisomes and (2) autolysosomes or residual bodies. The organelles were often found in close-proximity to phagophore-like structures. Immunogold labeling localized mutant HTT to non-fibrillar, electron lucent structures within the lumen of these organelles. In presymptomatic HD, the recruitment organelles were predominantly MVBs/amphisomes, whereas in late-stage HD, there were more autolysosomes or residual bodies. Electron tomograms indicated the fusion of small vesicles with the vacuole within the lumen, suggesting that MVBs develop into residual bodies. We found that markers of MVB-related exocytosis were depleted in presymptomatic mice and throughout the disease course. This suggests that endolysosomal homeostasis has moved away from exocytosis toward lysosome fusion and degradation, in response to the need to clear the chronically aggregating mutant HTT protein, and that this occurs at an early stage in HD pathogenesis.
Huntington’s disease (HD) is a late onset, inherited neurodegenerative disorder that manifests with psychiatric disturbances, movement disorders and cognitive decline . It is caused by a CAG repeat expansion in exon 1 of the huntingtin gene (HTT) that encodes an abnormally long polyglutamine (polyQ) tract in the huntingtin protein (HTT) . Individuals with CAG expansions of 35 or less remain unaffected, those with 40 or more will develop HD within a normal lifespan, and 36-39 CAGs confer an increasing risk of developing the disease . CAG expansions of approximately 65 or more can result in onset during childhood or adolescence . Huntingtin aggregates are deposited in the brains of HD patients in the form of inclusions that are predominantly cytoplasmic and scattered throughout the neuropil in cell bodies, dendrites and axons [12, 19]. They also occur as nuclear inclusions, the frequency of which increases with increasing CAG repeat length . Neuronal cell death occurs in the striatum, cortex and other brain regions [51, 76].
The propensity for mutant HTT to aggregate is governed by the extent of the polyQ expansion, and the length of the N-terminal HTT fragment in which it resides . The exon 1 HTT protein is particularly aggregation-prone . An incomplete splicing event that occurs in knockin mouse models of HD, as well as patient brains and cell lines, results in a small polyadenylated transcript that encodes this highly pathogenic protein [52, 67]. In addition to this, N-terminal fragments of mutant HTT are generated by the proteolysis of full-length HTT [17, 30, 37, 79]. Exon 1 HTT self-assembles in vitro to form insoluble end-stage amyloid-based fibrillar aggregates with a cross-β-sheet architecture [65, 69]. The initiating exon 1 HTT associations are thought to occur through α-helix-rich interactions of the first 17 amino acids (N17), leading initially to spherical, α-helix rich oligomeric structures [27, 58, 73]. This may enhance the elongation of a stochastically-formed polyQ β-hairpin, facilitating nucleation of a β-sheet-based amyloid structural motif [22, 80] to which additional exon 1 HTT monomers are recruited . Our recent description of a liquid to solid phase transition for exon 1 HTT proteins indicates that the mutant HTT aggregation process in cells may involve liquid-like assemblies prior to the formation of fibrillar structures or other stable aggregates . Regardless of the specific steps preceding nucleation, post-nucleation amyloid growth appears to proceed via oligomeric nanofibrils that possess key functional attributes of amyloid substructure: the ability to grow into mature fibrils by recruitment of monomeric exon 1 HTT [13, 80].
HTT inclusions have been shown to have a fibrillar sub-structure in vivo and cryo-electron tomography of exon 1 HTT inclusions in cell models also revealed a fibrillar structure that distorted the organization of the endoplasmic reticulum (ER) and perturbed ER membrane dynamics [5, 62, 68]. Inclusions in vivo are complex structures which sequester many other proteins  and may perturb multiple processes critical to cellular function. Cell culture experiments previously suggested that the formation of inclusions might be part of a homeostatic protective mechanism . However, subsequent experiments suggest that inclusions can be directly cytotoxic . A recent study showed that an aggregated form of exon 1 HTT, possessing a fundamental amyloid substructure, was the toxic species of mutant HTT in HD flies and transfected neurons, although the exact nature of this amyloid species, i.e. an inclusion, dispersed fibril cluster, or nanofibril, was not determined [13, 80]. The use of a seeding assay has demonstrated that minute quantities of small self-propagating exon 1 HTT fibrils were sufficient to dramatically shorten the lifespan of HD transgenic flies .
It was previously shown that a subset of cytoplasmic inclusion bodies in tissue sections from HD mouse models and HD patient post-mortem brains, termed “aggregation foci”, were competent to recruit polyQ peptides . Here, we set out to determine the ultrastructure of these recruitment foci, which appeared indistinguishable from nuclear and other cytoplasmic inclusions by anti-HTT antibody staining. We found that fluorescently labelled exon 1 HTT proteins were recruited to sites within neuronal cell bodies, in brain sections from two distinct HD mouse models, in a polyQ-length and disease-stage dependent manner. In order to identify the structures of these recruitment foci, we established a correlative light and electron microscopy (CLEM) procedure to co-locate fluorescent signals with EM images on the same brain section. We found that the exon 1 HTT proteins were recruited to single membrane-bound, vesicle-rich organelles that resembled multivesicular bodies (MVBs) or amphisomes, whereas others, with single or multiple vacuoles, resembled autolysosomes or residual bodies. Immunogold labelling localized the mutant HTT to non-fibrillar, electron-lucent regions within the lumen of these organelles. Our finding that markers of MVB-related exocytosis were depleted in presymptomatic HD mice provides further evidence to indicate that endolysosomal homeostasis is dysregulated at an early stage in HD pathogenesis.
Materials and methods
All procedures were performed in accordance with the Animals (Scientific Procedures) Act 1986 and were approved by the University College London Ethical Review Process Committee. zQ175 knock-in mice were generated by replacing exon 1 of mouse Htt with exon 1 from human HTT, carrying a highly expanded CAG repeat [21, 50] from which the neo selectable marker has been removed (delta neo)  and were bred by backcrossing zQ175 males to C57BL/6 J females (Charles River). R6/2 mice are transgenic for the 5′ region of the mutant human huntingtin (HTT) gene  and were bred by crossing R6/2 males to C57BL/6JOlaHsd x CBA/CaOlaHsd F1 females (B6CBAF1/OlaHsd, Envigo, Netherlands).
Within each colony, genetically modified and wild-type mice were group housed with up to five mice per cage, dependent on gender, but genotypes were mixed. Mice were housed in individually ventilated cages with Aspen Chips 4 Premium bedding (Datesand) with environmental enrichment which included chew sticks and play tunnel (Datesand). They had unrestricted access to food (Teklad global 18% protein diet, Envigo) and water. The temperature was regulated at 21 °C ± 1 °C and animals were kept on a 12 h light/dark cycle. The animal facility was barrier-maintained and quarterly non-sacrificial FELASA screens found no evidence of pathogens. For molecular analyses, mice were sacrificed by a schedule 1 procedure, brains were rapidly dissected, tissues were snap frozen in liquid nitrogen and stored at − 80 °C.
Genotyping and CAG repeat sizing
Genotyping and CAG repeat sizing were performed by PCR of ear-biopsy DNA and all primers were from Invitrogen. For zQ175 mice, a 20 μL genotyping reaction contained 10—15 ng DNA, GoTaq Flexi buffer, 2.5 mM MgCl2, 0.2 mM dNTPs, 1.0 μM 19Fhum [5′-AGGAGCCGCTGCACCGA-3′], 1.0 μM 431R2 [5′-CTCTTCACAACAGTCATGTGCG-3′] and 1.0 U GoTaq2 polymerase (Promega). Cycling conditions were 30 s at 98 °C, 34 x (15 s at 98 °C, 15 s at 64 °C, 30 s at 72 °C), 5 min at 72 °C. The amplified products were 324 bp for wild-type and 240 bp for zQ175. For R6/2 mice, a 10 μL reaction contained 50—100 ng DNA, 1.0 μM forward primer [5′-CGCAGGCTAGGGCTGTCAATCATGCT-3′], 1.0 μM reverse primer [5′-TCATCAGCTTTTCCAGGGTCGCCAT-3′], 1.0 μM forward internal control primer [5′-AGCCCTACACTAGTGTGTGTTACACA-3′], 1.0 μM reverse internal control primer [5′-CTTGTTGAGAACAAACTCCTGCAGCT-3′] and Dream Taq Hot Start Green PCR Master Mix (Thermo Fisher Scientific). Cycling conditions were 3 min at 95 °C, 34 × (30 s at 95 °C, 30 s at 60 °C, 1 min at 72 °C), 15 min at 72 °C.
For CAG repeat sizing for both zQ175 and R6/2, a 25 μL reaction contained 25–50 ng DNA, 0.2 μM FAM-labelled forward primer [5′-CCTTCGAGTCCCTCAAGTCCTT-3′], 0.2 μM reverse primer [5′-CGGCTGAGGCAGCAGCGGCTGT-3′], AmpliTaq Gold 360 Master Mix (Thermo Fisher Scientific) and GC enhancer (Thermo Fisher Scientific). Cycling conditions were 10 min at 95 °C, 34 × (30 s at 95 °C, 30 s at 63 °C and 90 s at 72 °C), 7 min at 72 °C. Samples were run on an ABI3730XL Genetic Analyser with MapMarker ROX 1000 (Bioventures) internal size standards and analyzed using GeneMapper v5 software (Thermo Fisher Scientific). The mean CAG repeat size for all zQ175 mice was 191.7 ± 4.6 (S.D.) and for R6/2 was 182.1 ± 1.8 (SD).
Recruitment assay with biotinylated peptides
The recruitment of the mbPEGQ30 peptide and subsequent immunohistochemistry was performed as described in  with modifications. In brief, mice were perfused and 30 μm free-floating brain sections prepared as described previously . Sections were washed in phosphate buffered saline (PBS) and treated with 1% sodium borohydride in PBS for 30 min. Borohydride was removed by washing three times in PBS. Sections were permeabilized and blocked by washing three times in PBS with 0.3% triton (PBST) and incubated overnight with 10 nM mbPEGQ30 in PBST at 4 °C. Rigorous washing was performed to remove unbound peptides with PBST over several hours at room temperature. Sections were then washed three times in PBS before signal amplification using Elite ABC reagent (Vector). Sections were washed three times in TI buffer (0.05 M Tris pH 7.4, 0.05 M Imidazole (Sigma) in PBS). Signals were amplified using the Tyramide Signal Amplification kit (Perkin Elmer) according to the manufacturer’s recommendations. The sections were then mounted on glass slides and processed through 70%, 90% and 100% alcohols and xylene before cover-slipping with DPX mountant (Sigma). Histological images were obtained using a Zeiss AxioSkop2 plus microscope fitted with a Zeiss AxioCam HRc colour camera. Images were recorded using Zeiss AxioVision 4.7.
Recruitment assay with fluorescent proteins and immunofluorescence
Free-floating brain sections were prepared as above. Sections were permeabilized in 0.3% PBST and washed three times in PBS. Sections were treated with TrueBlack (Cat No. 23007, Biotium) according to the manufacturer’s recommendations to quench autofluorescence. Control sections were always included to check for complete autofluorescence quenching. Sections were then incubated with exon1 HTT peptides at 50 nM in PBS overnight at 4 °C. Rigorous washing in 12 or 24 well plates four to six times of an excess of PBS was performed for 6 to 8 h at room temperature or for 24–48 h at 4 °C. For immunofluorescence, sections were incubated with primary antibodies (Additional File 1: Table S1) overnight at 4 °C. Sections were washed and incubated with secondary antibodies (all at 1:1000, Thermo Fisher Scientific) for 1 h at room temperature or overnight at 4 °C. Sections were counterstained with Hoechst and mounted for confocal microscopy.
Confocal microscopy and image analysis
Confocal imaging and analysis were performed as previously described with modifications . In brief, images were recorded on a Zeiss LSM710 confocal microscope by collecting random fields within hippocampal CA1, cortical or striatal regions. Imaging settings were kept consistent for wild-type and HD sections in each experiment. Sample autofluorescence levels were routinely checked by using additional imaging channels. Images were analysed with Fiji (RRID: SCR_002285) and Icy (Version 18.104.22.168; https://icy.bioimageanalysis.org; RRID: SCR_010587) software. Pearson correlation coefficients (PCCs) were calculated in Fiji using the JACoP plugin . To determine whether S830 labelling was enriched at the exon 1 HTT recruitment sites, these regions were identified by thresholding in the HTT-exon1-43Q channel, then squares centred on the HTT-exon1-43Q signal were randomly cropped, using only the HTT-exon1-43Q channel to guide cropping. If the cropped regions happened to contain large nuclear aggregates, visible in the S830 channel during downstream analysis, they were discarded. PCCs were then calculated using HTT-exon1-43Q and S830 channels in the cropped regions. As a negative control, pixels in the S830 channel were randomly shuffled using a custom python (https://www.python.org/) script and the PCCs were re-calculated. The same method was used to assess enrichment of LAMP1 at the exon1 HTT recruitment sites. The brightness and contrast were adjusted only for presentation purposes.
Correlative light and electron microscopy (CLEM)
CLEM was performed as described in [1, 33] with modifications. Mice were perfused with 4% paraformaldehyde (PFA), brains removed and immediately sectioned into 100 μm slices on a vibratome (Leica Microsystems), then incubated with fluorescently labelled HTT-exon1-43Q in 1 M phosphate buffer at 4 °C. Tissue sections were high-pressure frozen in 100 μm-deep wells of aluminium carriers in the presence of 20% bovine serum albumin (BSA, Sigma) using a HPM100 (Leica Microsystems). Freeze substitution and Lowicryl HM20 (Polysciences, Inc.) resin embedding were performed as previously described , and 0.008% uranyl acetate in acetone was used for freeze substitution. Sections of 70–300 nm thickness were cut with an Ultra 35° diamond knife (Diatome) on an ultramicrotome (Leica Microsystems). The sections were picked up with 200 mesh gold NH2 finder grids coated with holey QUANTIFOIL carbon film (hole size = 3.5 μm separated by 1 μm). For high-accuracy CLEM, 50 nm fluorescent TetraSpeck beads (custom order, Thermo Fisher Scientific) were adsorbed onto the grids for fluorescence light microscopy as described . For electron tomography, 10 nm gold particles (Electron Microscopy Sciences) were adsorbed onto both sides of the sections. A Tecnai F20 transmission electron microscope (TEM) (equipped with a Direct Electron DE-20 detector operated at 200 kV) or FEI Polara F30 TEM (fitted with a Quantum energy filter (Gatan) operated in zero-loss imaging mode with a 20 eV energy-selecting slit at 300 kV and a K2 Summit direct electron detector) were used to generate low magnification whole grid maps and intermediate magnification montage maps by Navigator using SerialEM [49, 70]. QUANTIFOIL carbon film holes and sample landmarks recognizable in both LM and EM were used for the initial correlation. Further fiducial-based correlation was done using the ec-CLEM plugin in Icy as described .
Immunogold labelling was performed as described in  with modifications. Ultrathin sections were prepared on QUANTIFOIL finder grids and fluorescence recorded as described above. Grids were incubated in 0.05 M glycine in Tris-buffered saline (TBS, pH 7.6) for 20 min and then incubated in blocking buffer (5% BSA and 0.1% cold water fish skin gelatine in TBS) for 15 min. After two 5 min washes in blocking buffer, the grids were transferred to incubation buffer (1% BSA and 0.1% cold water fish skin gelatine in TBS) containing anti-HTT antibodies (S830 or mEM48, both at 1:20) and incubated for 48–72 h at 4 °C in a humidified chamber. After three washes in the incubation buffer, the grids were incubated with secondary antibodies conjugated to 10 nm or 20 nm gold (ab39609 or ab27242, Abcam, at 1:50 dilution) for 1 h at room temperature. Grids washed three times in TBS and post-fixed in TBS containing 2% glutaraldehyde (Sigma) for 5 min. The grids were rinsed three times in distilled water and post-stained for TEM.
Electron tomography data collection and processing
Electron tomograms were collected using a FEI Tecnai T12 as previously described  or a FEI Tecnai G2 Polara operating at 300 kV and equipped with Quantum energy filter (Gatan) operated in zero-loss imaging mode with a 20 eV energy-selecting slit. Data were recorded on a K2 Summit direct electron detector (Gatan) operating in counting mode at dose rate 5.974 e− per pixel per second with a final sampling of 4.41 Å per pixel. Defocus ranged between − 3.5 and − 6 µm. The dose-symmetric tilt scheme  implemented in SerialEM  was used to collect tilt series between − 60° and 60°, with 3° increments and a total exposure of 600–700 e−/Å2. 60 frames were collected per tilt and aligned with MotionCor2 version 1.0.5 . Tomograms were reconstructed from tilt series by weighted back-projection using the IMOD package, version 4.9 . Tomography data have been deposited in the Electron Microscopy Data Bank (EMDB).
Western blotting was performed as previously described . Briefly, mouse hippocampal samples were homogenized in ice-cold IGEPAL RIPA buffer with protease inhibitors at 4 °C. 20 or 40 µg of total protein in Laemmli loading buffer was denatured at 85 °C for 10 min and separated by 7.5-, 10-, or 12% Criterion TGX Stain-free SDS-PAGE (Bio-Rad) and blotted onto 0.45 µm nitrocellulose membrane (Bio-Rad) by submerged transfer apparatus (Bio-Rad). Membranes were then blocked and incubated overnight with gentle agitation at 4 °C with the primary antibody (Additional File 1: Table S1). Protein was detected by chemiluminescence (Clarity, Bio-Rad) according to the manufacturer’s instructions and signals were captured on a ChemiDoc Touch MP Imaging System (Bio-Rad).
Quantification and statistical analysis
Statistical analyses were performed by Student’s t-test, one-way or two-way ANOVA with Šidák post-hoc correction in GraphPad Prism (Version 8) or Welch’s t-test in R (https://www.r-project.org/). p < 0.05 considered statistically significant; n represents animals or biological replicates. Where shown, ns = not significant, *p < 0.05, **p < 0.01, ***p < 0.001. For all graphs, the bars show mean values, while the error bars represent the standard deviation (SD).
Mutant exon 1 HTT proteins are recruited to a subset of the cytoplasmic inclusions in HD mouse brains
It had been demonstrated previously that synthetic, biotinylated polyQ peptides were recruited to aggregation foci in tissue sections from HD post-mortem brain and HD mouse models, but not to brain sections from control subjects or wild-type mice . To investigate this phenomenon further, we began by testing whether one of these peptides, 30 glutamines conjugated to biotin via a polyethylene glycol linker (mbPEGQ30), might be recruited to aggregates in brain sections from the zQ175 knockin mouse model of HD. We detected aggregates capable of polyQ peptide recruitment throughout the brain of heterozygous zQ175 mice (Fig. 1a). These recruitment foci did not necessarily co-localize with the HTT inclusions detected by anti-HTT antibodies (Fig. 1b), consistent with the previous report . The S830 anti-HTT antibody identified HTT aggregates in the form of small inclusion bodies in the nucleus and cytoplasm (Fig. 1b, blue arrowheads) as well as a diffuse granular stain that filled neuronal nuclei (Fig. 1b, purple arrows). In contrast, the mbPEGQ30 peptide was recruited to structures that appeared as defined puncta (Fig. 1b, black arrows), and these recruitment foci could be detected in the cortex and hippocampal CA1 region as early as three months of age.
To investigate the nature of the recruitment foci, we set out to determine whether these structures could recruit a fluorescently labelled exon 1 HTT protein. Exon 1 HTT, with a polyQ stretch of 43 glutamines (HTT-exon1-43Q), was synthesized as previously described [75, 78], and conjugated at the C-terminus with either an Alexa Fluor 488 (AF488) or Alexa Fluor 647 (AF647) dye. The fluorescently labelled exon 1 HTT proteins were applied to brain sections from zQ175 mice at 6 months of age and from R6/2 mice at 12 weeks of age, together with their respective wild-type littermate controls. At these ages, the zQ175 mice are presymptomatic and yet to present overt behavioral phenotypes [21, 50], with end-stage disease not occurring until approximately 20 months of age. However, R6/2 mice are symptomatic, having developed pronounced motor and cognitive impairments before 8 weeks of age [44, 60]. HTT-exon1-43Q was recruited to structures distributed throughout the brain sections for both zQ175 and R6/2 mice (Fig. 2a, b). The fluorescent signal was not quenched by either pre- or post-treatment with Trueblack (Additional File 1: Fig. S1), indicating that it did not represent autofluorescence. Next, we immunoprobed HTT-exon1-43Q treated sections with the S830 anti-HTT antibody and examined them for evidence of colocalization in the cortex, striatum and hippocampus. S830 detects nuclear aggregation in the form of a diffuse granular pattern as well as nuclear inclusions; it also labels cytoplasmic aggregates in the form of inclusion bodies that are perinuclear or scattered throughout the neuropil [10, 40] (Fig. 2a, b). Colocalization of HTT-exon1-43Q with S830 fluorescent signals was confined to perinuclear inclusions in both zQ175 and R6/2 mice (Fig. 2c). S830 was consistently enriched at exon 1 HTT recruitment sites (zQ175: PCC = 0.328 ± 0.048; R6/2: PCC = 0.478 ± 0.074). The colocalization was lost when pixels in the S830 channel were shuffled (zQ175 shuffled: PCC = − 0.002 ± 0.006; R6/2 shuffled: PCC = 0.006 ± 0.012) (Additional File 1: Fig. S2a, b).
Recruitment of the exon 1 HTT proteins to HD mouse brain sections was both disease-stage and polyQ-length dependent
To determine whether the extent of HTT-exon1-43Q recruitment to brain sections was dependent on disease progression, we applied HTT-exon1-43Q to coronal sections from R6/2 mice and their wild-type counterparts at 4, 8 and 12 weeks of age. The recruitment signal was prominent on sections from both 8- and 12-week-old mice (Fig. 3a). Although barely detectable by eye (Fig. 3a), quantification revealed a significant increase in the fluorescence intensity of HTT-exon1-43Q treated sections from R6/2 as compared to wild-type mice at 4 weeks of age (Fig. 3c). The recruitment foci intensities significantly increased in R6/2 mice with disease progression (Fig. 3c) and HTT-exon1-43Q was not recruited to sections from wild-type mice at any of these ages (Fig. 3a, c).
To investigate which structural domains within exon 1 HTT might be important for the HTT-exon1-43Q recruitment, we generated exon 1 HTT monomers with a range of polyQ lengths (15Q, 23Q, 43Q) and the HTT-exon1-43Q peptide lacking the first 17 amino acids (ΔN17-exon1-43Q). The first 17 amino acids of HTT are known to oligomerize through α-helix-rich interactions [27, 73] and the polyQ tracts interact though β-strand structures . These proteins were applied to coronal sections from zQ175 mice at 6 months and R6/2 mice at 12 weeks of age, respectively. Treatment of the zQ175 brain sections with HTT-exon1-15Q gave a comparable signal to the wild-type controls (Fig. 3b, d), and therefore 15 glutamines were not sufficient for recruitment on 6-month-old zQ175 brain sections. Whilst some AF488 signal was obtained with the HTT-exon 1-23Q peptide on zQ175 sections, the fluorescence intensities were not significantly increased over HTT-exon1-15Q (Fig. 3b, d). Treatment of the zQ175 brain sections with either HTT-exon1-43Q or ΔN17-exon1-43Q resulted in significantly increased fluorescence intensities compared to HTT-exon1-15Q and HTT-exon1-23Q (Fig. 3b, d). In contrast to 6-month-old zQ175 mice, both HTT-exon1-15Q and HTT-exon1-23Q were recruited to R6/2 sections from 12-week-old mice (Fig. 3b, e). The extent of recruitment was comparable for the HTT-exon1-43Q and ΔN17-43Q proteins (Fig. 3b) on both zQ175 (Fig. 3d) and R6/2 (Fig. 3e) sections. Therefore, the recruitment of exon 1 HTT proteins increased with disease progression and aggregate burden, and this interaction occurred through the polyQ tract.
HTT-exon1-43Q proteins are recruited to single membrane bound, vesicle-rich organelles
We next established a protocol for correlative light and electron microscopy (CLEM) to determine the ultrastructure of the recruitment foci. Coronal sections were prepared from zQ175 mice at 6 months of age, immediately after perfusion. The HTT-exon1-43Q-AF647 peptide was applied to the zQ175 sections, which were then subjected to high-pressure freezing and freeze substitution, and the recruitment sites in the hippocampal CA1 region were imaged. We found that the HTT-exon1-43Q-AF647 fluorescence signal was well-preserved following these procedures (Fig. 4a, c, magenta), and the autofluorescence of the CA1 region was negligible as shown by auto-exposure of the sample in the 488 nm channel (Fig. 4b). Ultrathin sections were collected on QUANTIFOIL finder EM grids and fluorescence light microscopy (LM) images were recorded (Fig. 4e). As shown in Fig. 4g, the recruitment sites were identified as single membrane bound, vesicle rich organelles (see Additional File 1: Fig. S3 for larger view of the organelle and Additional File 2: Video S1, for tomogram). In this example, the recruitment organelle (magenta) was adjacent to a double membrane, phagophore-like structure, as shown in the 3D segmentation from the tomogram (Fig. 4h, cyan).
We used fluorescent fiducials to provide markers in the field of view to accurately map fluorescence to electron micrographs, achieving an accuracy of less than 100 nm [1, 33]. TetraSpeck beads have a wide fluorescence spectrum and can be identified in both fluorescence channels (Fig. 4i, green and magenta) . The same sets of beads could be observed by both LM and EM as indicated by orange arrows in Fig. 4i-k. Whereas the beads were visible in multiple channels by LM, the recruitment signal was only seen in one channel (Fig. 4i, magenta), making it readily identifiable.
Tomography and 3D segmentation revealed that on this R6/2 section, HTT-exon1-43Q was again recruited to a single membrane bound, vesicle-rich structure containing a large vacuole (Fig. 4k, l). The organelle was close to a double membrane structure, either part of the endoplasmic reticulum (ER) or, once again, phagophore-like. Tomography and segmentation established that the organelle was in close-proximity to, but not in direct contact with, this double membrane structure (bottom right insert in Fig. 4l). These CLEM results demonstrated that the HTT-exon1-43Q proteins were recruited to similar, single membrane bound, vesicle-rich organelles in both zQ175 and R6/2 mice.
Mutant HTT is localized to the lumen of the recruitment organelles
In order to determine which structures within the recruitment organelles contain mutant HTT, we used immunogold labelling on R6/2 brain sections from 12-week-old mice. We first identified the recruitment foci by CLEM and then examined the immunogold labelling in those foci. Two anti-HTT antibodies were used: S830, labelled with 10 nm, and mEM48 labelled with 20 nm gold particles, respectively. Both S830 (Fig. 5a, c-f) and mEM48 (Fig. 5b) labelled mutant HTT within the recruitment foci (single membrane-bound organelles). In both cases, the gold particles were located in the lumen, especially in the electron lucent regions (Fig. 5d, f), but were absent from the large vacuoles (Fig. 5b, e). Three independent experiments revealed that, on average, the lumen of 93% of organelles examined contained S830 gold particles (in total 45 out of 47 recruitment foci) (Fig. 5g). The mEM48 labelling was sparser, with 61% of the organelles containing gold particles (Fig. 5g). The immunogold staining background was relatively clean for both S830 and mEM48, with very few gold particles identified in the background [on the QUANTIFOIL carbon hole (hole size = 3.5 μm in diameter) containing the recruitment foci of interest] (Fig. 5h). Although fibrillar material is well preserved in high pressure frozen, freeze-substituted samples, no fibrils were observed in the recruitment organelles.
The single-membrane organelles differ between presymptomatic and late-stage HD
Our CLEM investigations revealed similar recruitment organelle structures for the zQ175 knockin and R6/2 transgenic mouse models of HD. In both cases, they were single membrane-bound organelles, often containing vesicles. Those with many intraluminal vesicles (ILVs) resembled multivesicular bodies (MVBs) or amphisomes (Fig. 6a, b, e and Additional File 3: Video S2) [9, 11, 15, 66, 81]. Others, with prominent electron lucent vacuole(s), sometimes contained internal membranous structures (luminal lamellae), and resembled lysosomal organelles such as autolysosomes or residual bodies (Fig. 6c, d, f–h, Additional File 4: Video S3, and Additional File 5: Video S4) [7, 31, 34, 39]. Detailed analysis revealed that in zQ175 mice, on average, 71% of the recruitment organelles were MVBs/amphisomes while 29% were autolysosomes/residual bodies. In R6/2 mice, the number of MVBs/amphisomes was on average 38%, and the number of autolysosome/residual bodies was 62% (Fig. 6i).
Luminal lamellae were observed in some recruitment organelles in both zQ175 (Fig. 6c and Additional File 4: Video S3) and R6/2 (Fig. 6g, h) mice. In zQ175, only 6% of organelles (4 out of 71) had lamellar structures, whereas in R6/2, this number was 26% (28 out of 106) (Fig. 6j). Double membrane, phagophore-like structures were frequently observed in close-proximity to the recruitment organelles. In zQ175 mice, 34% (24 out of 71) of the organelles had an adjacent double membrane structure and in R6/2 mice, this was 28% (30 out of 106) (Fig. 6k).
Sequential sections through the 3D volumes of reconstructed tomograms suggest that vesicles fuse to form larger vacuoles within the recruitment organelles (Fig. 6l, m, Additional File 4: Video S3 and Additional File 5: Video S4).
The recruitment organelles are members of the endolysosomal pathway
We next confirmed by confocal fluorescence microscopy that the recruitment organelles identified by CLEM were a subset of endolysosomal organelles. HTT-exon1-43Q proteins were applied to brain sections from 6-month-old zQ175 mice, which were then immunoprobed for the lysosomal-associated membrane protein 1 (LAMP1), a marker which labels MVBs through to lysosomal organelles , and the anti-HTT antibody, S830. As indicated by white arrowheads (Fig. 7a–d), and intensity profiles (Fig. 7e, f), the HTT-exon1-43Q recruitment signal colocalized with a subset of puncta that were LAMP1 and S830 positive. For the recruitment signal and LAMP1 colocalization, an enrichment of LAMP1 at the recruitment sites was found (PCC = 0.483 ± 0.027), which was lost when the pixels in the LAMP1 channel were shuffled (PCC = 0.002 ± 0.004) (Additional File 1: Fig. S2c). LAMP1 was also found to reside in numerous subcellular locations that were negative for the recruitment signal (Fig. 7b, e, f). Therefore, the HTT-exon1-43Q protein was recruited to a subset of LAMP1 positive endolysosomal organelles.
Dysregulation of endolysosomal markers in presymptomatic and late-Stage HD
We next examined whether the endolysosomal system had been altered by measuring total protein levels of endolysosomal markers that recognize early endosomes through to autolysosomes in zQ175 and R6/2 mice and their wide-type littermates. Antibodies to RAB5 (early endosome), RAB7 and M6PR (MVB/late endosome), RAB 11 (recycling endosomes), RAB27 and CD63 (exosomes), LAMP1 (MVBs to autolysosomes) and cathepsin B and cathepsin D (lysosomal proteases) were used to probe western blots of hippocampal lysates from R6/2 mice and their wild-type littermates at 4, 8 and 12 weeks of age (Additional File 1: Fig. S4). Reductions in LAMP1, RAB7, RAB27 and CD63, and an increase in cathepsin B were identified in R6/2 as compared to wild-type lysates (Additional File 1: Fig. S4). LAMP1, RAB7, RAB27, CD63 and cathepsin B antibodies were then used to determine whether these proteins were altered in hippocampal lysates from zQ175 mice at 6 months of age, and the western blots of hippocampal lysates from 8- and 12-week-old R6/2 mice were repeated with a larger number of samples. We found that levels of RAB27 and CD63, both involved in MVB related exocytosis [24, 54, 82], were reduced in the 6-month-old zQ175 and 8- and 12-week-old R6/2 lysates (Fig. 8). Cathepsin B was increased in the 8- and 12-week R6/2 lysates, but not in those from zQ175 mice at 6 months of age (Fig. 8). To conclude, our data suggest that the endolysosomal system is dysregulated in HD and that this occurs at an early, presymptomatic stage.
Precise CLEM targeting of pathological mutant HTT deposits in mouse models of HD has revealed a structure and cellular pathway that were entirely unpredicted by previous in vitro and cell models of HTT aggregation. We show that a subset of cytoplasmic antibody-detected ‘inclusions’ in the brains of HD mouse models are single membrane-bound, vesicle-rich organelles. These predominantly resemble MVBs or amphisomes in presymptomatic mice and are more likely to resemble autolysosomes or residual bodies at later stages of the disease course. Immunogold labelling localized mutant HTT to non-fibrillar, electron-lucent regions within the lumen of these organelles. We discovered that proteins important for exosome function were depleted in presymptomatic mice providing further evidence that the endolysosomal system is dysregulated in HD.
In this study, we set out to uncover the structures in tissue sections from mouse models of HD to which polyQ peptides are recruited. To facilitate the potential application of CLEM we tested the use of exon 1 HTT proteins chemically conjugated with fluorescent tags. We utilized two complementary mouse models: R6/2 mice that are transgenic for a human exon 1 HTT  and the zQ175 knockin HD mouse model  with comparable mean CAG repeat expansions of 182 and 192 CAGs, respectively. R6/2 mice progress to end-stage disease by around 14 weeks, whereas disease progression in zQ175 mice is more protracted, with end-stage disease occurring at approximately 20 months of age. We studied the zQ175 mice at 6 months of age prior to symptom onset and analyzed R6/2 mice over their disease course up to 12 weeks, allowing us to study late-stage disease in the absence of confounds due to ageing. Overall, we demonstrated that recruitment of the HTT-exon1-43Q protein occurred through the polyQ tract, in an N17 independent manner, and increased with disease progression. We showed that in all cases, exon 1 HTT proteins with 15Q, 23Q and 43Q polyQ repeat lengths were recruited to sections from 12 week-old R6/2 mice, consistent with the ability of aggregates, once amyloid growth has been nucleated, to bind proteins containing polyQ tracts whether or not the polyQ is in the HD pathogenic range .
At the resolution of confocal microscopy, antibody staining identifies inclusion bodies in neuronal nuclei and throughout the neuropil in the brains of HD mouse models and HD patients [10, 12, 19, 40]. On the nanoscale, nuclear inclusions are compact, membrane-less fibril-containing assemblies [10, 74]. Consistent with the recruitment of the biotinylated polyQ peptide , we found that the HTT-exon1-43Q peptide was not recruited to nuclear inclusions, but instead, to a subset of cytoplasmic sites in the cell body. Structures of polyQ containing aggregates have previously been identified by CLEM in yeast cells, immortalized cell lines and primary mouse neurons that overexpress an expanded polyQ, showing that the deposition of aggregates depends greatly on the cellular environment and context [5, 18, 57, 62]. Application of correlative microscopy to tissue sections is much more challenging. Previously, it has been used to uncover the structure of Lewy bodies in Parkinson’s disease post-mortem brain sections, by correlating LM and EM images on adjacent sections, revealing vesicle-rich, mainly non fibrillar aggregates . Unfortunately, this method was not applicable for our study due to the challenge of fluorescent labelling after osmium tetroxide treatment and the smaller size of the recruitment foci. Instead, we successfully adapted a high-precision CLEM methodology originally developed for mammalian and yeast cells [1, 33]. This allowed us to correlate LM and EM on the same mouse brain sections at an accuracy of < 100 nm, consistent with the cell-based studies [1, 33].
Our CLEM analysis revealed that these recruitment foci were single membrane-bound, vesicle-rich structures. Those with many intraluminal vesicles (ILVs) resembled MVBs or amphisomes [9, 11, 15, 66, 81] and others, containing vacuole(s) and in some cases internal membranous structures (luminal lamellae), resembled autolysosomes or residual bodies [7, 31, 34, 39]. The presence of luminal lamellae has been associated with various lysosomal storage diseases [11, 35]. Here we found more organelles containing luminal lamellae in late-stage HD, possibly due to the accumulation of cellular lipids in lysosomes as a result of lysosomal dysfunction. However, we cannot exclude the possibility that some of the membranous structures came directly from the cellular organelles/debris engulfed by autophagy. Therefore, the exact mechanism of lamellae formation, and how it relates to HD, requires further investigation. The proportions of MVB-like structures and autolysosomes in zQ175 and R6/2 brains at 6 months and 12 weeks of age, respectively, suggested that the MVBs/amphisomes transition to autolysosomes/residual bodies during disease progression. In support of this, examination of membrane contacts in the 3D reconstructions provided evidence of vesicle fusion to form the large vacuole within the autolysosomes. Double membrane phagophore-like structures were frequently observed in close-proximity to the recruitment organelles in both zQ175 and R6/2 mice, an association that might be underestimated. TEM images of the sections were used to estimate the number of cases in which phagophore-like double membranes were associated with the organelles. Since some associated phagophore-like structures might lie outside the plane of the section, the true number of associations could be greater. On the other hand, we cannot exclude the possibility that some of these double membranes are smooth ER. Future studies with large volume 3D EM reconstruction will be valuable in further clarifying this association.
The endolysosomal pathway links exosome biogenesis and autophagy and is important in responding to stress and maintaining homeostasis in health and disease [14, 81] (Fig. 9). Early endosomes mature into MVBs which are late endocytic compartments containing many ILVs. MVBs can fuse with the plasma membrane, releasing the intraluminal vesicles into the extracellular space as exosomes. Through the process of macroautophagy, cytoplasmic proteins and organelles are engulfed by the double membraned phagophore to form autophagosomes, which fuse with lysosomes to degrade the contents. Alternatively, autophagosomes can fuse with MVBs to form hybrid organelles termed amphisomes, which are thought to eventually fuse with lysosomes. Amphisomes can also fuse with the plasma membrane and secrete their contents (Fig. 9a).
We demonstrated by immunogold antibody labelling that mutant HTT is localized within the recruitment organelles, in electron lucent areas. Whilst no discernible fibrils or other structures were detected, the presence of small aggregates, well under 10 nm in diameter, cannot be excluded, and such nanostructures could act as polyQ recruitment centres. Why would aggregated HTT within the organelles recruit the exon 1 proteins, when fibrillar aggregates present at other locations in the cell, e.g. the nucleus, do not? It is possible that the acidic environment of these organelles has rendered aggregated HTT competent for HTT-exon1-43Q recruitment, possibly by stripping extraneous, non-specifically bound components from the growing end, or by inducing a more disordered state in which the polyQ region is more accessible to the label. The aggregated HTT present in the organelles may have entered the endolysosomal pathway via autophagy, through the fusion of autophagosomes with MVBs to form amphisomes. Aggregated HTT may have been incorporated into the lumen of MVBs/endosomes, as occasionally, we observed immunogold HTT associated with small vesicular structures next to the recruitment organelles, an observation that requires further investigation (Fig. 9b). Alternatively, exogenous exon 1 HTT aggregates have been shown to be taken up by endocytosis and directed to lysosomal compartment in both mitotic and nonmitotic neuroblastoma cells , although it is not known whether this process occurs in vivo.
MVBs and the endosome-lysosome system have been previously implicated in HD pathogenesis. HTT antibodies have been shown to bind to MVBs in HD patient brains  and functional MVBs were required for the efficient clearance of HTT aggregates via autophagic degradation . Transfection of clonal striatal rat cells with HTT constructs stimulated the endosomal–lysosomal pathway, endosomal tubulation and the number, size and morphological variability of autophagic vacuoles and lysosome-like bodies . RAB5 has been reported to recruit HTT to early endosomes via huntingtin associated protein 40 (HAP40) and mutant HTT results in altered endosome motility and endocytic activity . In addition, inhibition of RAB5 enhanced polyQ toxicity in cell and fly models, potentially identifying a novel role for RAB5 in the early stages of autophagosome formation . Mutant HTT impairs vesicle formation from recycling endosome by interfering with RAB11 activity , which is disrupted in a knockin mouse model of HD  and slows the recycling of the EAAC1 glutamate/cysteine transporter to the plasma membrane, leading to deficient glutathione synthesis and oxidative stress . Our data are consistent with these reports in which total levels of RAB11 were not changed in HD .
Our data suggest that mutant HTT dysregulates exocytosis in vivo, a novel mechanism through which mutant HTT disrupts the endolysosomal pathway (Fig. 9b). We found that the exosome proteins RAB27a and CD63 were both decreased by up to 30% in hippocampal lysates from zQ175 mice aged 6 months and R6/2 mice aged 8 and 12 weeks (Fig. 8), indicating that the depletion of these proteins occurs throughout the entire disease course in these mouse models. CD63 is a tetraspanin that is enriched on the ILVs that are secreted as exosomes , and RAB27 functions in MVB docking at the plasma membrane . These changes could reflect a shift in endolysosomal homeostasis away from exocytosis toward lysosome fusion and degradation, in response to the need to clear the chronically aggregating mutant HTT (Fig. 9b). In support of this, we detected an increase in cathepsin B in hippocampal lysates form 8- and 12-week-old R6/2 mice (Fig. 8c-f). Mutant HTT might induce a block in the pathway at the MVB / amphisome / autolysosome stages, a hypothesis supported by the frequently observed phagophore-like structures that appear poised to engulf the recruitment organelles (Fig. 9b).
We have established a method to correlate fluorescence microscopy images with their underlying EM-resolved structures on the same brain sections from mouse models of HD. In the work presented here, the fluorescent signal resulted from the recruitment of labelled exon 1 HTT proteins. This allowed us to determine the ultrastructure of a subset of the puncta seen by antibody staining and confocal microscopy. We have now adapted CLEM for use with fluorescently labelled antibodies on tissue sections to determine whether other aggregated HTT-rich puncta might contain alternative HTT aggregated states, or more complex structures as have been discovered for Lewy bodies in Parkinson’s disease [38, 46, 71]. Causative and risk-associated mutations, for a broad spectrum of neurodegenerative diseases, have been identified in many genes involved in the endolysosomal and autophagic pathways . Our demonstration that proteins important for MVB-related exocytosis are considerably depleted throughout the disease course in vivo provides further evidence demonstrating that the endolysosomal pathway is dysregulated in HD and is likely to contribute to the pathogenic process.
Availability of data and materials
Representative tomograms have been deposited in the Electron Microscopy Data Bank (EMDB), accession codes are EMD-12374, EMD-12376, EMD-12536 and EMD-12539. The datasets generated and/or analysed during the current study are available from the corresponding authors on reasonable request.
Correlative light and electron microscopy
Multiple vesicular body
Phosphate buffer saline
Polymerase chain reactions
Transmission electron microscopy
Pearson correlation coefficients
Ader NR, Kukulski W (2017) triCLEM: combining high-precision, room temperature CLEM with cryo-fluorescence microscopy to identify very rare events. Methods Cell Biol 140:303–320. https://doi.org/10.1016/bs.mcb.2017.03.009
Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805–810. https://doi.org/10.1038/nature02998
Ast A, Buntru A, Schindler F, Hasenkopf R, Schulz A, Brusendorf L, Klockmeier K, Grelle G, McMahon B, Niederlechner H, Jansen I, Diez L, Edel J, Boeddrich A, Franklin SA, Baldo B, Schnoegl S, Kunz S, Purfurst B, Gaertner A, Kampinga HH, Morton AJ, Petersen A, Kirstein J, Bates GP, Wanker EE (2018) mHTT seeding activity: a marker of disease progression and neurotoxicity in models of Huntington’s disease. Mol Cell 71:675–688. https://doi.org/10.1016/j.molcel.2018.07.032
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005. https://doi.org/10.1038/nrdp.2015.5
Bauerlein FJB, Saha I, Mishra A, Kalemanov M, Martinez-Sanchez A, Klein R, Dudanova I, Hipp MS, Hartl FU, Baumeister W, Fernandez-Busnadiego R (2017) In situ architecture and cellular interactions of PolyQ inclusions. Cell 171:179–187. https://doi.org/10.1016/j.cell.2017.08.009
Bolte S, Cordelieres FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213–232. https://doi.org/10.1111/j.1365-2818.2006.01706.x
Castro-Chavira SA, Aguilar-Vazquez AR, Martinez-Chavez Y, Palma L, Padilla-Gomez E, Diaz-Cintra S (2016) Effects of chronic malnourishment and aging on the ultrastructure of pyramidal cells of the dorsal hippocampus. Nutr Neurosci 19:329–336. https://doi.org/10.1179/1476830515Y.0000000009
Cheng XT, Xie YX, Zhou B, Huang N, Farfel-Becker T, Sheng ZH (2018) Characterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neurons. J Cell Biol 217:3127–3139. https://doi.org/10.1083/jcb.201711083
Clague MJ, Urbe S (2008) Multivesicular bodies. Curr Biol 18:R402–R404. https://doi.org/10.1016/j.cub.2008.02.068
Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537–548. https://doi.org/10.1016/s0092-8674(00)80513-9
Demais V, Barthelemy A, Perraut M, Ungerer N, Keime C, Reibel S, Pfrieger FW (2016) Reversal of pathologic lipid accumulation in NPC1-deficient neurons by drug-promoted release of LAMP1-coated lamellar inclusions. J Neurosci 36:8012–8025. https://doi.org/10.1523/JNEUROSCI.0900-16.2016
DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990–1993. https://doi.org/10.1126/science.277.5334.1990
Drombosky KW, Rode S, Kodali R, Jacob TC, Palladino MJ, Wetzel R (2018) Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington’s disease. Neurobiol Dis 120:126–138. https://doi.org/10.1016/j.nbd.2018.08.019
Fader CM, Colombo MI (2009) Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ 16:70–78. https://doi.org/10.1038/cdd.2008.168
Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerod L, Fisher EM, Isaacs A, Brech A, Stenmark H, Simonsen A (2007) Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol 179:485–500. https://doi.org/10.1083/jcb.200702115
Franich NR, Hickey MA, Zhu C, Osborne GF, Ali N, Chu T, Bove NH, Lemesre V, Lerner RP, Zeitlin SO, Howland D, Neueder A, Landles C, Bates GP, Chesselet MF (2019) Phenotype onset in Huntington’s disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene. J Neurosci Res 97:1590–1605. https://doi.org/10.1002/jnr.24493
Gafni J, Hermel E, Young JE, Wellington CL, Hayden MR, Ellerby LM (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. J Biol Chem 279:20211–20220. https://doi.org/10.1074/jbc.M401267200
Gruber A, Hornburg D, Antonin M, Krahmer N, Collado J, Schaffer M, Zubaite G, Luchtenborg C, Sachsenheimer T, Brugger B, Mann M, Baumeister W, Hartl FU, Hipp MS, Fernandez-Busnadiego R (2018) Molecular and structural architecture of polyQ aggregates in yeast. Proc Natl Acad Sci USA 115:E3446–E3453. https://doi.org/10.1073/pnas.1717978115
Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington’s disease: relationship to neuropathology. J Neurosci 19:2522–2534
Hagen WJH, Wan W, Briggs JAG (2017) Implementation of a cryo-electron tomography tilt-scheme optimized for high resolution subtomogram averaging. J Struct Biol 197:191–198. https://doi.org/10.1016/j.jsb.2016.06.007
Heikkinen T, Lehtimaki K, Vartiainen N, Puolivali J, Hendricks SJ, Glaser JR, Bradaia A, Wadel K, Touller C, Kontkanen O, Yrjanheikki JM, Buisson B, Howland D, Beaumont V, Munoz-Sanjuan I, Park LC (2012) Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington’s disease. PLoS ONE 7:e50717. https://doi.org/10.1371/journal.pone.0050717
Hoop CL, Lin HK, Kar K, Magyarfalvi G, Lamley JM, Boatz JC, Mandal A, Lewandowski JR, Wetzel R, van der Wel PC (2016) Huntingtin exon 1 fibrils feature an interdigitated beta-hairpin-based polyglutamine core. Proc Natl Acad Sci USA 113:1546–1551. https://doi.org/10.1073/pnas.1521933113
Hori A, Peddie CJ, Collinson LM, Toda T (2015) Centriolar satellite- and hMsd1/SSX2IP-dependent microtubule anchoring is critical for centriole assembly. Mol Biol Cell 26:2005–2019. https://doi.org/10.1091/mbc.E14-11-1561
Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, Tyska MJ, Weaver AM (2013) Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep 5:1159–1168. https://doi.org/10.1016/j.celrep.2013.10.050
Hosp F, Gutierrez-Angel S, Schaefer MH, Cox J, Meissner F, Hipp MS, Hartl FU, Klein R, Dudanova I, Mann M (2017) Spatiotemporal proteomic profiling of Huntington’s disease inclusions reveals widespread loss of protein function. Cell Rep 21:2291–2303. https://doi.org/10.1016/j.celrep.2017.10.097
Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell 72:971–983. https://doi.org/10.1016/0092-8674(93)90585-e
Jayaraman M, Kodali R, Sahoo B, Thakur AK, Mayasundari A, Mishra R, Peterson CB, Wetzel R (2012) Slow amyloid nucleation via alpha-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol 415:881–899. https://doi.org/10.1016/j.jmb.2011.12.010
Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci USA 96:11404–11409. https://doi.org/10.1073/pnas.96.20.11404
Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, Aronin N, DiFiglia M (2000) Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20:7268–7278
Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington’s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci USA 98:12784–12789. https://doi.org/10.1073/pnas.221451398
Klumperman J, Raposo G (2014) The complex ultrastructure of the endolysosomal system. Cold Spring Harb Perspect Biol 6:a016857. https://doi.org/10.1101/cshperspect.a016857
Kremer JR, Mastronarde DN, McIntosh JR (1996) Computer visualization of three-dimensional image data using IMOD. J Struct Biol 116:71–76. https://doi.org/10.1006/jsbi.1996.0013
Kukulski W, Schorb M, Welsch S, Picco A, Kaksonen M, Briggs JA (2011) Correlated fluorescence and 3D electron microscopy with high sensitivity and spatial precision. J Cell Biol 192:111–119. https://doi.org/10.1083/jcb.201009037
Lai JKF, Sam IC, Verlhac P, Baguet J, Eskelinen EL, Faure M, Chan YF (2017) 2BC non-structural protein of enterovirus A71 interacts with SNARE proteins to trigger autolysosome formation. Viruses. https://doi.org/10.3390/v9070169
Lajoie P, Guay G, Dennis JW, Nabi IR (2005) The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies. J Cell Sci 118:1991–2003. https://doi.org/10.1242/jcs.02324
Landles C, Milton RE, Ali N, Flomen R, Flower M, Schindler F, Gomez-Paredes C, Bondulich MK, Osborne GF, Goodwin D, Salsbury G, Benn CL, Sathasivam K, Smith EJ, Tabrizi SJ, Wanker EE, Bates GP (2020) Subcellular localization and formation of huntingtin aggregates correlates with symptom onset and progression in a Huntington’s disease model. Brain Commun 2:fcaa66. https://doi.org/10.1093/braincomms/fcaa066
Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, Sun B, Gafni J, Ellerby LM, Trottier Y, Richards WG, Osmand A, Paganetti P, Bates GP (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 285:8808–8823. https://doi.org/10.1074/jbc.M109.075028
Lashuel HA (2020) Do Lewy bodies contain alpha-synuclein fibrils? and does it matter? A brief history and critical analysis of recent reports. Neurobiol Dis 141:104876. https://doi.org/10.1016/j.nbd.2020.104876
Lee JH, Tecedor L, Chen YH, Monteys AM, Sowada MJ, Thompson LM, Davidson BL (2015) Reinstating aberrant mTORC1 activity in Huntington’s disease mice improves disease phenotypes. Neuron 85:303–315. https://doi.org/10.1016/j.neuron.2014.12.019
Li H, Li SH, Cheng AL, Mangiarini L, Bates GP, Li XJ (1999) Ultrastructural localization and progressive formation of neuropil aggregates in Huntington’s disease transgenic mice. Hum Mol Genet 8:1227–1236. https://doi.org/10.1093/hmg/8.7.1227
Li X, Sapp E, Chase K, Comer-Tierney LA, Masso N, Alexander J, Reeves P, Kegel KB, Valencia A, Esteves M, Aronin N, Difiglia M (2009) Disruption of Rab11 activity in a knock-in mouse model of Huntington’s disease. Neurobiol Dis 36:374–383. https://doi.org/10.1016/j.nbd.2009.08.003
Li X, Standley C, Sapp E, Valencia A, Qin ZH, Kegel KB, Yoder J, Comer-Tierney LA, Esteves M, Chase K, Alexander J, Masso N, Sobin L, Bellve K, Tuft R, Lifshitz L, Fogarty K, Aronin N, DiFiglia M (2009) Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activity. Mol Cell Biol 29:6106–6116. https://doi.org/10.1128/MCB.00420-09
Li X, Valencia A, Sapp E, Masso N, Alexander J, Reeves P, Kegel KB, Aronin N, Difiglia M (2010) Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington’s disease. J Neurosci 30:4552–4561. https://doi.org/10.1523/JNEUROSCI.5865-09.2010
Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB (1999) Selective discrimination learning impairments in mice expressing the human Huntington’s disease mutation. J Neurosci 19:10428–10437
Liu KY, Shyu YC, Barbaro BA, Lin YT, Chern Y, Thompson LM, James Shen CK, Marsh JL (2015) Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington’s disease. Hum Mol Genet 24:1602–1616. https://doi.org/10.1093/hmg/ddu574
Mahul-Mellier AL, Burtscher J, Maharjan N, Weerens L, Croisier M, Kuttler F, Leleu M, Knott GW, Lashuel HA (2020) The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci USA 117:4971–4982. https://doi.org/10.1073/pnas.1913904117
Malik BR, Maddison DC, Smith GA, Peters OM (2019) Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain 12:100. https://doi.org/10.1186/s13041-019-0504-x
Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493–506. https://doi.org/10.1016/s0092-8674(00)81369-0
Mastronarde DN (2005) Automated electron microscope tomography using robust prediction of specimen movements. J Struct Biol 152:36–51. https://doi.org/10.1016/j.jsb.2005.07.007
Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, Ghavami A, Brunner D, Park LC, Ramboz S, Howland D (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington’s disease: zQ175. PLoS ONE 7:e49838. https://doi.org/10.1371/journal.pone.0049838
Nana AL, Kim EH, Thu DC, Oorschot DE, Tippett LJ, Hogg VM, Synek BJ, Roxburgh R, Waldvogel HJ, Faull RL (2014) Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington’s disease. J Huntingt Dis 3:45–64. https://doi.org/10.3233/JHD-140092
Neueder A, Landles C, Ghosh R, Howland D, Myers RH, Faull RLM, Tabrizi SJ, Bates GP (2017) The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients. Sci Rep 7:1307. https://doi.org/10.1038/s41598-017-01510-z
Osmand AP, Berthelier V, Wetzel R (2006) Imaging polyglutamine deposits in brain tissue. Methods Enzymol 412:106–122. https://doi.org/10.1016/S0076-6879(06)12008-X
Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12:19–30. https://doi.org/10.1038/ncb2000
Pal A, Severin F, Lommer B, Shevchenko A, Zerial M (2006) Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington’s disease. J Cell Biol 172:605–618. https://doi.org/10.1083/jcb.200509091
Paul-Gilloteaux P, Heiligenstein X, Belle M, Domart MC, Larijani B, Collinson L, Raposo G, Salamero J (2017) eC-CLEM: flexible multidimensional registration software for correlative microscopies. Nat Methods 14:102–103. https://doi.org/10.1038/nmeth.4170
Peskett TR, Rau F, O’Driscoll J, Patani R, Lowe AR, Saibil HR (2018) A liquid to solid phase transition underlying pathological Huntingtin Exon1 aggregation. Mol Cell 70:588–601. https://doi.org/10.1016/j.molcel.2018.04.007
Poirier MA, Li H, Macosko J, Cai S, Amzel M, Ross CA (2002) Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J Biol Chem 277:41032–41037. https://doi.org/10.1074/jbc.M205809200
Pols MS, Klumperman J (2009) Trafficking and function of the tetraspanin CD63. Exp Cell Res 315:1584–1592. https://doi.org/10.1016/j.yexcr.2008.09.020
Rattray I, Smith E, Gale R, Matsumoto K, Bates GP, Modo M (2013) Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HD. PLoS ONE 8:e60012. https://doi.org/10.1371/journal.pone.0060012
Ravikumar B, Imarisio S, Sarkar S, O’Kane CJ, Rubinsztein DC (2008) Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J Cell Sci 121:1649–1660. https://doi.org/10.1242/jcs.025726
Riguet N, Mahul-Mellier A-L, Maharjan N, Burtscher J, Patin A, Croisier M, Knott G, Reiterer V, Farhan H, Lashuel HA (2020) Disentangling the sequence, cellular and ultrastructural determinants of Huntingtin nuclear and cytoplasmic inclusion formation. bioRxiv:2020.2007.2029.226977. https://doi.org/10.1101/2020.07.29.226977
Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, Chotai K, Connarty M, Crauford D, Curtis A, Curtis D, Davidson MJ, Differ AM, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Hayden MR et al (1996) Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats. Am J Hum Genet 59:16–22
Ruiz-Arlandis G, Pieri L, Bousset L, Melki R (2016) Binding, internalization and fate of Huntingtin Exon1 fibrillar assemblies in mitotic and nonmitotic neuroblastoma cells. Neuropathol Appl Neurobiol 42:137–152. https://doi.org/10.1111/nan.12258
Sahoo B, Singer D, Kodali R, Zuchner T, Wetzel R (2014) Aggregation behavior of chemically synthesized, full-length huntingtin exon1. Biochemistry 53:3897–3907. https://doi.org/10.1021/bi500300c
Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997) Huntingtin localization in brains of normal and Huntington’s disease patients. Ann Neurol 42:604–612. https://doi.org/10.1002/ana.410420411
Sathasivam K, Neueder A, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RL, Roos RA, Howland D, Detloff PJ, Housman DE, Bates GP (2013) Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci USA 110:2366–2370. https://doi.org/10.1073/pnas.1221891110
Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549–558. https://doi.org/10.1016/s0092-8674(00)80514-0
Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington’s disease pathology. Proc Natl Acad Sci USA 96:4604–4609. https://doi.org/10.1073/pnas.96.8.4604
Schorb M, Haberbosch I, Hagen WJH, Schwab Y, Mastronarde DN (2019) Software tools for automated transmission electron microscopy. Nat Methods 16:471–477. https://doi.org/10.1038/s41592-019-0396-9
Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, Castano-Diez D, Schweighauser G, Graff-Meyer A, Goldie KN, Sutterlin R, Huisman E, Ingrassia A, Gier Y, Rozemuller AJM, Wang J, Paepe A, Erny J, Staempfli A, Hoernschemeyer J, Grosseruschkamp F, Niedieker D, El-Mashtoly SF, Quadri M, Van IWFJ, Bonifati V, Gerwert K, Bohrmann B, Frank S, Britschgi M, Stahlberg H, Van de Berg WDJ, Lauer ME (2019) Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22:1099–1109. https://doi.org/10.1038/s41593-019-0423-2
Telenius H, Kremer HP, Theilmann J, Andrew SE, Almqvist E, Anvret M, Greenberg C, Greenberg J, Lucotte G, Squitieri F et al (1993) Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum Mol Genet 2:1535–1540. https://doi.org/10.1093/hmg/2.10.1535
Thakur AK, Jayaraman M, Mishra R, Thakur M, Chellgren VM, Byeon IJ, Anjum DH, Kodali R, Creamer TP, Conway JF, Gronenborn AM, Wetzel R (2009) Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol 16:380–389. https://doi.org/10.1038/nsmb.1570
Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc Natl Acad Sci USA 97:8093–8097. https://doi.org/10.1073/pnas.110078997
Vieweg S, Ansaloni A, Wang ZM, Warner JB, Lashuel HA (2016) An intein-based strategy for the production of tag-free Huntingtin Exon 1 proteins enables new insights into the polyglutamine dependence of Httex1 aggregation and fibril formation. J Biol Chem 291:12074–12086. https://doi.org/10.1074/jbc.M116.713982
Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369–384. https://doi.org/10.1097/00005072-199805000-00001
Wagner AS, Politi AZ, Ast A, Bravo-Rodriguez K, Baum K, Buntru A, Strempel NU, Brusendorf L, Hanig C, Boeddrich A, Plassmann S, Klockmeier K, Ramirez-Anguita JM, Sanchez-Garcia E, Wolf J, Wanker EE (2018) Self-assembly of mutant Huntingtin Exon-1 fragments into large complex fibrillar structures involves nucleated branching. J Mol Biol 430:1725–1744. https://doi.org/10.1016/j.jmb.2018.03.017
Warner JBT, Ruff KM, Tan PS, Lemke EA, Pappu RV, Lashuel HA (2017) Monomeric Huntingtin Exon 1 has similar overall structural features for wild-type and pathological polyglutamine lengths. J Am Chem Soc 139:14456–14469. https://doi.org/10.1021/jacs.7b06659
Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, Graham RK, Loubser O, van Raamsdonk J, Singaraja R, Yang YZ, Gafni J, Bredesen D, Hersch SM, Leavitt BR, Roy S, Nicholson DW, Hayden MR (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington’s disease. J Neurosci 22:7862–7872
Wetzel R (2020) Exploding the repeat length paradigm while exploring amyloid toxicity in Huntington’s disease. Acc Chem Res 53:2347–2357. https://doi.org/10.1021/acs.accounts.0c00450
Xu J, Camfield R, Gorski SM (2018) The interplay between exosomes and autophagy—partners in crime. J Cell Sci. https://doi.org/10.1242/jcs.215210
Zhang Y, Xu C, Nan Y, Nan S (2020) Microglia-derived extracellular vesicles carrying miR-711 alleviate neurodegeneration in a murine Alzheimer’s disease model by binding to Itpkb. Front Cell Dev Biol 8:566530. https://doi.org/10.3389/fcell.2020.566530
Zheng SQ, Palovcak E, Armache JP, Verba KA, Cheng Y, Agard DA (2017) MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods 14:331–332. https://doi.org/10.1038/nmeth.4193
Zhou Y, Howell FV, Glebov OO, Albrecht D, Williams G, Doherty P (2016) Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLalpha) generates distinct cellular pools; implications for endocannabinoid signaling. Mol Cell Neurosci 76:76–86. https://doi.org/10.1016/j.mcn.2016.08.011
We thank Natalya Lukoyanova for help with the EM data collection and comments on the manuscript, Lucy Collinson and Christopher Peddie for technical advice and David Houldershaw for computing support.
This work was supported by grants from the CHDI Foundation, Wellcome Trust awards 106249/Z/14/Z and 079605/2/06/2 and the UK Dementia Research Institute, which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Tomogram related to Fig. 4g, a recruitment site (segmented in magenta) identified by CLEM in 6-month-old zQ175 mice.
Tomogram related to Fig. 6b, mutant HTT containing organelle resembles MVB/amphisome in 6-month-old zQ175 mice.
Tomogram related to Fig. 6c, mutant HTT containing organelle resembles autolysosome in 6-month-old zQ175 mice. Intraluminal lamellar structures are segmented in cyan.
Tomogram related to Fig. 6d, mutant HTT containing organelle resembles autolysosome/residual body in 6-month-old zQ175 mice.
About this article
Cite this article
Zhou, Y., Peskett, T.R., Landles, C. et al. Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease. acta neuropathol commun 9, 70 (2021). https://doi.org/10.1186/s40478-021-01172-z
- Huntington’s disease
- Correlative light and electron microscopy
- Electron tomography
- Huntingtin aggregation
- Endolysosomal system
- Multivesicular body